Hematology Diagnostics Market Size, Share, Trends & Forecast
The Hematology Diagnostics Market is expanding as healthcare laboratories increase investment in automation, high-throughput testing, and connected diagnostic platforms. MRFR estimates that the market reached USD 4.49 billion in 2025 and is projected to reach USD 8.71 billion by 2035, registering a CAGR of 7.16%.
Laboratory automation is one of the strongest forces shaping market development. Shortages of trained laboratory professionals are encouraging healthcare organizations to adopt automated analyzers that can process routine blood tests efficiently while reducing dependence on manual workflows.
The transition from standalone systems toward integrated platforms is also influencing purchasing decisions. Five- and six-part differential analyzers accounted for 47.8% of the technology segment in 2024, reflecting demand for higher-throughput systems capable of supporting modern laboratory operations.
Complete blood count testing remains the foundation of hematology diagnostics, generating the largest test-type revenue. Hospitals are particularly important end users, with hospital laboratories accounting for 43.1% of demand in 2024.
Going forward, connected analyzers, digital morphology, AI-assisted workflows, and automated laboratory operations are expected to create further opportunities. Vendors combining reliable instruments with software, consumables, and service-based models may be well positioned to benefit from continued laboratory modernization.
Gain valuable insights through comprehensive industry analysis:
Healthcare Consulting Service Market Forecast
LASIK Eye Surgery Market Outlook